Portfolio Reach Domain Associates has a long track record and extensive network in life sciences with over 250 portfolio companies formed and decades of experience, suggesting strong cross-sell across pharma, diagnostics, and medical devices opportunities.

Funded Growth With $2.4 billion in capital under management and multiple funds raised, Domain is positioned to consider follow-on investments, co-investments, or strategic partnerships in late-stage startups and growth-stage life science ventures.

Strategic Focus The firm’s specialization in pharmaceuticals, diagnostics, and medical devices indicates alignment potential for vendors offering integrated life science solutions, contract development services, or platform technologies relevant to portfolio companies.

Global Collaborations Domain’s engagement in international collaborations (Russia, China via Rusnano and Beijing Elite) signals openness to global partnerships and regional market expansion conversations that can be explored for distribution, licensing, or joint ventures.

Technology Stack Domain’s tech usage (cloud services, secure email, and web technologies) implies a readiness to adopt or recommend modern digital tools and data services; potential fit for technology vendors offering security, compliance, or efficiency-enhancing solutions tailored to venture-backed life sciences firms.